NCT06183840

Brief Summary

This multicenter randomized controlled non-inferiority trial of only mesh fixation with a glue applicator is a trial to evaluate the outcomes between atraumatic laparoscopic mesh fixation with GLUTACK-Glubran2® and conventional traumatic fixation, so the primary endpoint of the study is to analyze the recurrence on ventral or incisional hernia repair 2 years postoperatively assessed by a clinical and/or imaging technique.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Mar 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Mar 2024Dec 2026

First Submitted

Initial submission to the registry

November 6, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 28, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

March 10, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

March 6, 2024

Status Verified

March 1, 2024

Enrollment Period

10 months

First QC Date

November 6, 2023

Last Update Submit

March 4, 2024

Conditions

Keywords

Ventral herniaIncisional herniaMeshGlueTackersIPOM plus

Outcome Measures

Primary Outcomes (1)

  • Rate of the recurrence on ventral or incisional hernia repair 2 years postoperatively assessed by a clinical and/or imaging technique.

    The fixation of the mesh with atraumatic material with glue is as good as the conventional traumatic fixation

    2 years

Secondary Outcomes (3)

  • Rate of postoperative pain between atraumatic and traumatic fixation of the mesh (EuraHS Quality of life scale: 0-10). Ten is the worst outcome

    2 years

  • Types of comorbidities related on the surgery as visceral adhesions, seroma, hematoma, bulging, port site incisional hernia, recurrence

    2 years

  • Quality of life (QoL) between the two types of fixations with the EuraHS scale at 1 month, 6 months, 12 months, and 24 months. EurasHS scale of 10 is the worst outcome

    2 years

Study Arms (2)

Conventional

ACTIVE COMPARATOR

Patients with a traumatic fixation of the mesh

Device: Conventional

Glutack

EXPERIMENTAL

Patient with Glutack mesh fixation

Device: Glutack

Interventions

GlutackDEVICE

Three ports are used (1x11 mm and 2x5 mm) and after adhesiolysis and the field prepared, the defect is measured with a local standard in a craneo-caudal and transversal directions. Then, the defect is closed with a 2-0 caliber barbed suture following its biggest axis. A Dynamesh IPOM previously hydrated (2-3 min) is introduced throughout the 11mm trocar and extended. After this maneuver, mesh fixation is performed depending on the randomized arm: Glutack

Glutack

Three ports are used (1x11 mm and 2x5 mm) and after adhesiolysis and the field prepared, the defect is measured with a local standard in a craneo-caudal and transversal directions. Then, the defect is closed with a 2-0 caliber barbed suture following its biggest axis. A Dynamesh IPOM previously hydrated (2-3 min) is introduced throughout the 11mm trocar and extended. After this maneuver, mesh fixation is performed depending on the randomized arm: Traumatic fixation

Also known as: Traumatic fixation
Conventional

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adults with a BMI lesser than 35 Kg/m2 undergoing an elective laparoscopic primary ventral or incisional hernia repair with a fascial transverse defect between 4-8 cm (W2 EHS) on anterior or lateral location (M1-M5 up to 10 cm of length or L1-3)
  • ASA grade from I-II
  • Informed consent signed

You may not qualify if:

  • Patients less than 18 years and over 80 years of age.
  • Fascial transverse defect less than 4 cm and more than 8 cm.
  • Recurrent ventral or incisional hernia in the same place
  • Emergency surgery
  • Procedure involving concomitant surgeries (e.g. gastrointestinal, biliary or genitourinary surgery)
  • BMI greater than 35 Kg/m2
  • ASA III-IV
  • Pregnancy
  • Tobacco

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hernia, VentralIncisional Hernia

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Abdominal Wall Unit Surgery

Study Record Dates

First Submitted

November 6, 2023

First Posted

December 28, 2023

Study Start

March 10, 2024

Primary Completion

December 31, 2024

Study Completion (Estimated)

December 31, 2026

Last Updated

March 6, 2024

Record last verified: 2024-03